Renk to sell slide bearings unit to Miba, trims 2026 earnings outlook

Renk agreed to sell its slide bearings unit to Austria’s Miba for an undisclosed price, with Jefferies indicating a low- to mid-three-digit-million-euro range; the transaction remains subject to regulatory approvals. Renk now forecasts 2026 revenue of about €1.4 billion and adjusted EBIT of €240 million–€255 million for continuing operations, which Jefferies said is a slight cut versus its estimates of €1.45 billion and €261 million. The disposal sharpens Renk’s defense focus as it targets defense at around 90% of revenue by 2030; the article provides no Renk share-price reaction.

Analysis

The strategic benefit is a cleaner defense mix and potential redeployment of capital/capacity, but the near-term signal is weaker continuing-business expectations: Renk’s 2026 outlook sits below Jefferies’ ex-disposal estimates for both sales and adjusted EBIT. That creates a risk the market pays for a defense-purity rerating while estimates are still moving down. The unit sale price is undisclosed; Jefferies’ roughly €280m present-value estimate is an analyst benchmark, not evidence of the agreed consideration. Compare the eventual proceeds with that benchmark and with the unit’s projected €26m of 2028 adjusted EBIT before calling the disposal value-accretive.

Over the next 1–3 months, the key catalysts are transaction terms, regulatory approval, and any revision to continuing-operation guidance. A lower-than-benchmarked price or further EBIT reductions would outweigh the portfolio-simplification story. Over 6–18 months, the thesis depends on Renk converting released capital and capacity into defense growth without disrupting the integrated civilian/defense Marine & Industry business. Miba gains an industrial bearings asset and could benefit from scale, but the deal alone does not establish a material competitive threat to Renk’s retained businesses.

The contrarian point: a higher defense revenue share is not automatically higher earnings quality or valuation—customer concentration, program timing, and execution can offset any defense multiple premium. No compelling immediate directional trade without transaction pricing and evidence of defense reinvestment.

Key Decisions for Investors

• Keep R3NK on event watch rather than buying the strategic-focus narrative immediately; reassess when consideration, expected net proceeds, and use of capital are disclosed.
• Treat the 2026 continuing-business outlook as the near-term estimate anchor. A further adjusted-EBIT cut or failure to explain the gap to Jefferies’ €261m estimate would argue against adding exposure.
• Consider adding R3NK only if the sale price is defensible against the analyst’s roughly €280m present-value benchmark and management provides measurable defense capacity or order-conversion milestones; these are verification tests, not established deal economics.
• Falsifiers: a sale price materially below the benchmark, regulatory delay, further continuing-business guidance reductions, or evidence that disposal proceeds do not support defense execution. Conversely, estimate stabilization and successful redeployment would weaken the cautious view.